Clinical Trial Update: Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003 [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating progression-free survival in advanced colorectal cancer patients treated with AMT2003 has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• AMT2003

Snippet

Sponsor: Auron Healthcare GmbH | Conditions: Colorectal Carcinoma | Phase 2, Phase 3 | Status: TERMINATED